Share this post on:

Product Name :
Acazicolcept

Search keywords :
ICOS

drugId :
null

Target Vo:
Inducible T-cell costimulator

Target Vo Short Name :
ICOS

Moa_Name:
Inducible T-cell costimulator inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Alpine Immune Sciences Inc

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Lupus Erythematosus, Systemic

In Active Indication_Name:
Graft vs Host Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HIF1 beta Antibody
GFP Antibody
FOXO4 Antibody: FOXO4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to FOXO4. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related